AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE
Amgen (NASDAQ:AMGN) announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference scheduled for September 9, 2025, at 9:15 a.m. ET. The company will be represented by Peter Griffith, Executive Vice President and CFO, and Kave Niksefat, Senior Vice President of Global Marketing and Access.
The presentation will be accessible through a live webcast on Amgen's website (www.amgen.com) under the Investors section and will remain available for replay for at least 90 days following the event.
[]Amgen (NASDAQ:AMGN) ha annunciato la propria partecipazione al Morgan Stanley 23rd Annual Global Healthcare Conference, in programma per il 9 settembre 2025 alle 9:15 ET. All'evento interverranno Peter Griffith, Executive Vice President e CFO, e Kave Niksefat, Senior Vice President of Global Marketing and Access.
La presentazione sar脿 trasmessa in diretta via webcast sul sito di Amgen (www.amgen.com) nella sezione Investors e sar脿 disponibile in replica per almeno 90 giorni dopo l'evento.
Amgen (NASDAQ:AMGN) anunci贸 su participaci贸n en el Morgan Stanley 23rd Annual Global Healthcare Conference, programado para el 9 de septiembre de 2025 a las 9:15 a.m. ET. La compa帽铆a estar谩 representada por Peter Griffith, Executive Vice President y CFO, y Kave Niksefat, Senior Vice President of Global Marketing and Access.
La presentaci贸n se podr谩 ver en directo mediante un webcast en la p谩gina web de Amgen (www.amgen.com) en la secci贸n Investors y quedar谩 disponible en reproducci贸n durante al menos 90 d铆as tras el evento.
Amgen (NASDAQ:AMGN)鞚赌 Morgan Stanley 23rd Annual Global Healthcare Conference鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨溂氅�, 鞚检爼鞚赌 2025雲� 9鞗� 9鞚� 鞓れ爠 9鞁� 15攵�(霃欕秬 鞁滉皠)鞛呺媹雼�. 須岇偓電� Peter Griffith(Executive Vice President 氚� CFO)鞕� Kave Niksefat(Senior Vice President of Global Marketing and Access)臧� 雽�響滊 彀胳劃頃╇媹雼�.
氚滍憸電� Amgen 鞗轨偓鞚错姼(www.amgen.com)鞚� Investors 靹轨厴鞚� 韱淀暣 霛检澊敫� 鞗轨簮鞀ろ姼搿� 鞁滌箔頃� 靾� 鞛堨溂氅�, 頄夓偓 頉� 斓滌唽 90鞚缄皠 雼れ嫓氤搓赴搿� 鞝滉车霅╇媹雼�.
Amgen (NASDAQ:AMGN) a annonc茅 sa participation 脿 la Morgan Stanley 23rd Annual Global Healthcare Conference, pr茅vue le 9 septembre 2025 脿 9h15 (heure de l'Est). La soci茅t茅 sera repr茅sent茅e par Peter Griffith, Executive Vice President et CFO, et Kave Niksefat, Senior Vice President of Global Marketing and Access.
La pr茅sentation sera diffus茅e en direct via webcast sur le site d'Amgen (www.amgen.com) dans la rubrique Investors et restera disponible en replay pendant au moins 90 jours apr猫s l'茅v茅nement.
Amgen (NASDAQ:AMGN) gab seine Teilnahme an der Morgan Stanley 23rd Annual Global Healthcare Conference bekannt, die f眉r den 9. September 2025 um 9:15 Uhr ET angesetzt ist. Das Unternehmen wird durch Peter Griffith, Executive Vice President und CFO, sowie Kave Niksefat, Senior Vice President of Global Marketing and Access, vertreten.
Die Pr盲sentation wird per Live-Webcast auf der Amgen-Website (www.amgen.com) im Bereich Investors 眉bertragen und bleibt mindestens 90 Tage nach der Veranstaltung als Wiedergabe verf眉gbar.
- None.
- None.
The webcast, as with other selected presentations regarding developments in听Amgen's business given by management at certain investor and medical conferences, can be found on听Amgen's website,听, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on听Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
础产辞耻迟听础尘驳别苍
Amgen听discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago,听Amgen听helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today.听Amgen听is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.听
In 2024,听Amgen听was named one of the "World's Most Innovative Companies" by听Fast Company听and one of "America's Best Large Employers" by Forbes, among other听external recognitions.听Amgen听is one of the 30 companies that comprise the Dow Jones Industrial Average庐, and it is also part of the Nasdaq-100 Index庐, which includes the largest and most innovative non-financial companies listed on the听Nasdaq Stock Market听based on market capitalization.听
For more information, visit听Amgen.com听and follow us on听X听(formerly known as Twitter),听LinkedIn,听Instagram,听YouTube听补苍诲听Threads.
CONTACT: Amgen,
Elissa Snook, 609-251-1407 (media)听
Adam Elinoff, 805-490-9578 (investors)听鈥�
听
View original content to download multimedia:
SOURCE Amgen
FAQ
When is Amgen (NASDAQ:AMGN) presenting at the Morgan Stanley Healthcare Conference 2025?
Who will represent Amgen at the Morgan Stanley Healthcare Conference 2025?
How can investors access Amgen's Morgan Stanley Conference presentation?
How long will Amgen's Morgan Stanley Conference presentation be available for replay?
